Article info

Download PDFPDF
Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma

Authors

  • Jasmine H Francis Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA Department of Ophthalmology, Weill Cornea Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Brian P Marr Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA Department of Ophthalmology, Weill Cornea Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Paula Schaiquevich Unidad de Farmacocinética Clínica, Hospital de Pediatría JP Garrahan, Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Michael G Kellick Pediatric Pharmacy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • David H Abramson Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA Department of Ophthalmology, Weill Cornea Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Jasmine H Francis, Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA; francij1{at}mskcc.org
View Full Text

Citation

Francis JH, Marr BP, Schaiquevich P, et al
Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma

Publication history

  • Received January 13, 2015
  • Revised February 9, 2015
  • Accepted February 11, 2015
  • First published April 29, 2015.
Online issue publication 
September 22, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.